PACE-CME

SGLT2i: Overview of recent trials and guideline recommendations

SGLTi Overview of recent trials and guideline recommendations
RestartResume
10' education - Oct. 28, 2021 - Prof. Nikolaus Marx, MD - Online CME
  • Overview

    This presentation by prof. Marx is the second part of a series on tackling cardiorenal risk in patients with diabetes. He provides an overview of clinical trials with SGLT2 inhibitors and current recommendations in guidelines.

  • Educational information

    This lecture by Nicolaus Marx was part of an accredited symposium " Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia" held during the virtual EASD 2021.

  • Faculty

    Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

  • Funding

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free